TMPRSS2 and prostate neoplasm: Close inspection of data reveals that in several prostate tumors tested negative for the TMPRSS2:ERG rearrangement, TDRD1 is expressed at high levels despite low ERG expression, suggesting that ERG may not be the only factor which is capable of activating TDRD1 transcription.